Fig. 6From: The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjectsPlot of inhibition of ex vivo CXCL1-induced CD11b expression versus whole blood concentration of danirixin for Study 1. The plot shows all timepoints where results are available for both danirixin whole blood concentration and ex vivo CXCL1-induced CD11b expressionBack to article page